Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chiara A. Mesturino"'
Autor:
Michela Dal Pos, Francesco Zen, Mario Lamonica, M. Masin, Natalino Simioni, Giovanni Sartore, C. Cardone, Chiara Alberta Mesturino, Sara Balzano, Alberto Marangoni, Barbara Bonsembiante, Federica Tadiotto, Maria Grazia Dal Frà, Virgilio Da Tos, Narciso Marin, Vera Frison, Alessandro Pianta, G. Bax, Alessandra Gallo, Maria Simoncini, Michele D׳Ambrosio, Maria Ferrari, Paola Rocchini, Elisabetta Brun, Marco Strazzabosco, Giuseppe Panebianco, Michela Bettio, Annunziata Lapolla, Loris Confortin, F. Piarulli
Publikováno v:
Clinical therapeutics. 37(3)
Treatment with liraglutide in randomized controlled trials is associated with significant reductions in glycated hemoglobin (HbA1c) and weight loss in type 2 diabetes patients. The aim of this retrospective observational study was to investigate corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9456b96903f59797f9e0cf79841c769
https://pubmed.ncbi.nlm.nih.gov/25626486
https://pubmed.ncbi.nlm.nih.gov/25626486
Autor:
Isabella Cascino, John Osborn, Marco Capizzi, Antonio Petrone, Gabriele Giorgi, Chiara A. Mesturino, Raffaella Buzzetti, Umberto Di Mario, Lorenza Nisticò
Publikováno v:
Scopus-Elsevier
Hashimoto's thyroiditis (HT) is an autoimmune disease resulting from a complex interaction between genetic and environmental factors. The genetic loci conferring susceptibility need to be still defined. The aim of the present study was to determine w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140fc685c447e9151f84a80d05345189
https://doi.org/10.1089/105072501300042901
https://doi.org/10.1089/105072501300042901
Autor:
Giancarlo De Mattia, Maria Luisa Manca Bitti, Alberto Signore, Rita Amoretti, Rossana Fiori, M. Cervoni, F. Ferrazzoli, N. Visalli, Luigi Pisano, Concetta Suraci, Elvira Fioriti, S Corbi, A. Crinò, Dario Pitocco, S Spera, Maria R. Cassone Faldetta, Carlo Teodonio, Maria Gisella Cavallo, Francesco Paci, Lucio Lucentini, Nicoletta Sulli, G. Marietti, Chiara A. Mesturino, Giovanni Ghirlanda, Carla Bizzarri, Raffaella Buzzetti, M. C. Matteoli, Marco Giorgio Baroni, Paolo Pozzilli, Brunetto Boscherini, G. Multari
Publikováno v:
Diabetes/Metabolism Research and Reviews. 15:181-185
Background Intensive insulin therapy is the gold standard by which Type 1 diabetes is treated. In addition to this therapy, administration of nicotinamide (NA) can be beneficial. This concept is reinforced by the results of a recent meta-analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91af304fcb62a227fdb53514ae4e3eb2
https://doi.org/10.1002/(sici)1520-7560(199905/06)15:3<181::aid-dmrr31>3.0.co
https://doi.org/10.1002/(sici)1520-7560(199905/06)15:3<181::aid-dmrr31>3.0.co